Trial Profile
High-dose influenza vaccine (Fluzone HD) in the elderly compared to standard-dose influenza vaccine (Fluzone) in the elderly and adults aged 18-49 years, an immunogenicity and safety study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 17 Nov 2011 New trial record
- 23 Oct 2011 As reported in results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
- 23 Oct 2011 Results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.